EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases

Limei Cui, Yujuan Yang, Yan Hao, Hongfei Zhao, Yu Zhang, Tong Wu, Xicheng Song

Clinical Reviews in Allergy & Immunology · 10.02.2025 · 68 (1)

DOI: 10.1007/s12016-024-09019-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Reviews in Allergy & Immunology, online erschienen am 10.02.2025. Verfasst von Limei Cui und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, Qingdao Medical College, Qingdao University, Yantai Yuhuangding Hospital, Qingdao University, Ya…. Hauptthemen laut MEDLINE: Drug Delivery Systems, Nanotechnology, Inflammation, Respiratory Tract Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Shandong Province, Shandong Postdoctoral Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Under the concept of “one airway, one disease”, upper and lower airway inflammatory diseases share similar pathogenic mechanisms and are collectively referred to as airway inflammatory diseases. With industrial development and environmental changes, the incidence of these diseases has gradually increased. Traditional treatments, including glucocorticoids, antihistamines, and bronchodilators, have alleviated much of the discomfort experienced by patients. However, conventional drug delivery routes have inherent flaws, such as significant side effects, irritation of the respiratory mucosa, and issues related to drug deactivation. In recent years, nanomaterials have emerged as excellent carriers for drug delivery and are being increasingly utilized in the treatment of airway inflammatory diseases. These materials not only optimize the delivery of traditional medications but also facilitate the administration of various new drugs that target novel pathways, thereby enhancing the treatment outcomes of inflammatory diseases. This study reviews the latest research on nano-drug delivery systems used in the treatment of airway inflammatory diseases, covering traditional drugs, immunotherapy drugs, antimicrobial drugs, plant-derived drugs, and RNA drugs. The challenges involved in developing nano-delivery systems for these diseases are discussed, along with a future outlook. This review offers new insights that researchers can utilize to advance further research into the clinical application of nano-drug delivery systems for treating airway inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Delivery SystemsNanotechnologyInflammationRespiratory Tract DiseasesHumansAnimalsNanoparticles

Stichwörter der Autor:innen

Airway inflammatory diseasesImmunotherapy drug deliveryNano-delivery systemsRNA drug deliveryTraditional drug delivery

Autor:innen und Institutionen

  • Department of Otolaryngology, Head and Neck Surgery, Qingdao Medical College, Qingdao University, Yantai Yuhuangding Hospital, Qingdao University, Yantai, 264000, China.
  • Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, Yantai, 264000, China.
  • Shandong Provincial Clinical Research Center for Otorhinolaryngologic Diseases, Yantai, 264000, China.
  • Shandong University of Traditional Chinese Medicine, Jinan, 250000, Shandong, China.
  • Department of Otolaryngology, Head and Neck Surgery, Qingdao Medical College, Qingdao University, Yantai Yuhuangding Hospital, Qingdao University, Yantai, 264000, China. superzhang013@163.com.
  • Shandong Provincial Key Laboratory of Neuroimmune Interaction and Regulation, Yantai, 264000, China. superzhang013@163.com.

Förderung

  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Shandong Province
  • Shandong Postdoctoral Innovation Program
  • Medical and Health Science and Technology Development Program of Shandong Province
  • National Natural Science Foundation of China
  • Major Scientific and Technological Innovation Project of Shandong Province

Zitieren

APA

Cui, L., Yang, Y., Hao, Y., Zhao, H., Zhang, Y., Wu, T., & Song, X. (2025). Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases. Clinical Reviews in Allergy & Immunology, 68(1). https://doi.org/10.1007/s12016-024-09019-w

Vancouver

Cui L, Yang Y, Hao Y, Zhao H, Zhang Y, Wu T, et al. Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases. Clinical Reviews in Allergy & Immunology. 2025;68(1). doi:10.1007/s12016-024-09019-w

BibTeX
@article{Cui2025,
  author = {Cui, Limei and Yang, Yujuan and Hao, Yan and Zhao, Hongfei and Zhang, Yu and Wu, Tong and Song, Xicheng},
  title = {Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases},
  journal = {Clinical Reviews in Allergy & Immunology},
  year = {2025},
  volume = {68},
  number = {1},
  doi = {10.1007/s12016-024-09019-w}
}
Kostenlos starten →